Bio-business in brief: The challenges of clinical trials

Current Science

Volumn 93, Issue 10, 2007, Pages 1367-1375

  Mehdiratta, Ritu ^a   Parida, Deepak Kumar ^b   Saberwal, Gayatri ^a  

^a Institute of Bioinformatics and Applied Biotechnology   (India)

^b VIT UNIVERSITY   (India)

Author keywords

Bio business; Clinical trial; Ethics

Indexed keywords

EID: 36949039439     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Grey, B. H., Cooke, R. A. and Tannenbaum, A. S., Research involving human subjects. Science, 1978, 210, 1094-1101.
2. Kulkarni, N. and Srinivas Rao, Ch., Clinical trials angling for take off. BioSpectrum, 2004, 2, 22-30.
3. Nundy, S., Chir, M. and Gulhati, C. M., A new colonialism? Conducting clinical trials in India. N. Engl. J. Med., 2005, 352, 1633-1636.
4. Mathew, J. C., Clinically correct. Business Standard, 7 February 2007.
5. Usdin, S., Doing business in India. Biocentury, 2004, 12, A3.
6. Eichenwald, K. and Kolata, G., Drug trials hide conflicts for doctors New York Times, 1999; http://query.nytimes.com/gst/full-page.html?sec= health&res=9C02E3DF143EF935A25756C0A96F958260
7. Angell, M., The ethics of clinical research in the Third World. N. Engl. J. Med., 1997, 337, 847-849.
8. Padma, T. V., India's drug tests. Nature, 2005, 436, 485.
9. Vastag, B., The policy outlook from the Hill. Nature Biotechnol., 2007, 25, 13.
10. Cohen, J., Clinical trial monitoring: hit or miss? Science, 1994, 264, 1534-1537.
11. Baird, P., Downie, J. and Thompson, J., Clinical trials and industry. Science, 2002, 297, 2211.
12. Agnew, B., Financial conflicts get more scrutiny in clinical trials. Science, 2000, 289, 1266-1267.
13. Felten, D. L., IRBs: Going too far or not doing enough? Science, 2006, 313, 1388.
14. Caulfield, T., Legal and ethical issues associated with patient recruitment in clinical trials: The case of competitive enrollment. Health Law Rev., 2005, 13, 58-61.
15. Snyderman, R. and Holmes, E. W., Oversight mechanisms for clinical research. Science, 2000, 287, 595-597.
16. Green, L. A., Lowery, J. C., Kowalski, C. P. and Wyszewianski, L., Impact of institutional review board practice variation on observational health services research. Health Serv. Res., 2006, 41, 214-230.
17. Gunsalus, C. K. et al., Mission creep in the IRB world. Science, 2006, 312, 1441.
18. Mann, J. M., Zion, D., Macpherson, C. C. and Bloom, B. B., The ethics of AIDS vaccine trials. Science, 1998, 280, 1327.
19. Marino, I. R. and Cirillo, C., Clinical trials or exploitation? Science, 2004, 306, 54-55.
20. Enserink, M. and Malakoff, D., The trials of Thomas Butler. Science, 2003, 302, 2054-2063.
21. DeCosta, A., D'Souza, N., Krishnan, S., Chhabra, M. S., Shihaam, I. and Goswami, K., Community based trials and informed consent in rural north India. J. Med. Ethics, 2004, 30, 318-323.
22. Balaram, P., The ethical minefields of biomedical research. Curr. Sci., 2001, 81, 329-330.
23. Saberwal, G., Discussant at national consultation on 'New Reproductive Technologies and Their Implications for Women', Jawaharlal Nehru University, New Delhi, 4 January 2007.
24. Enserink, M., Are placebo-controlled drug trials ethical? Science, 2000, 288, 416.
25. Sen, F. and Muthuswamy, V., Building and managing clinical trial capacity in India: challenges in ethics, equity and efficiency. Report of the interactive workshop (ICMR-ASCI-Fordham) 21/22 October 2005, Hyderabad, available at homepage.mac.com/falsen
26. Sen, F. and Muthuswamy, V., Capacity building for clinical trials in India. Indian J. Med. Res., 2006, 124, 605-607.